Replies to post #94 on Builders FirstSource, Inc. (BLDR)

[Zephyr]

wasn't worth it imho. short covering....now it'll fall from here on out. They have nothing left to do but to do years worth of more trials and present again to the FDA. That's only a maybe. Z